Globe Roche Logo


Two specific genetic mutations significantly increase the risk of thrombophilia: the Factor V Leiden and the Factor II (Prothrombin) mutation 20210.

These mutations are associated with a significantly elevated risk of developing blood-clotting disorders. Statistically, both mutations are most likely to be found in populations in northern Europe.

The Factor V Leiden Kit and the Factor II (Prothrombin) G20210A Kit enables the detection and genotyping of a single-point mutation in both genes, helping healthcare professionals gain a broader understanding of patients’ risk factors to develop individualized treatment approaches.